Cargando…

SS18-SSX drives CREB activation in synovial sarcoma

PURPOSE: Synovial sarcoma (SySa) is a rare soft tissue tumor characterized by a reciprocal t(X;18) translocation. The chimeric SS18-SSX fusion protein represents the major driver of the disease, acting as aberrant transcriptional dysregulator. Oncogenic mechanisms whereby SS18-SSX mediates sarcomage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cyra, Magdalene, Schulte, Miriam, Berthold, Ruth, Heinst, Lorena, Jansen, Esther-Pia, Grünewald, Inga, Elges, Sandra, Larsson, Olle, Schliemann, Christoph, Steinestel, Konrad, Hafner, Susanne, Simmet, Thomas, Wardelmann, Eva, Kailayangiri, Sareetha, Rossig, Claudia, Isfort, Ilka, Trautmann, Marcel, Hartmann, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187574/ https://www.ncbi.nlm.nih.gov/pubmed/35556229 http://dx.doi.org/10.1007/s13402-022-00673-w

Ejemplares similares

Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone
por: Isfort, Ilka, et al.
Publicado: (2019)

Requirement for YAP1 signaling in myxoid liposarcoma
por: Trautmann, Marcel, et al.
Publicado: (2019)

Recurrent CTNNB1 mutations in craniofacial osteomas
por: Baumhoer, Daniel, et al.
Publicado: (2021)

Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers
por: Rossig, Claudia, et al.
Publicado: (2018)

The Cellular Tumor Immune Microenvironment of Childhood Solid Cancers: Informing More Effective Immunotherapies
por: Holterhus, Malcolm, et al.
Publicado: (2022)

Fusion protein-driven IGF-IR/PI3K/AKT signals deregulate Hippo pathway promoting oncogenic cooperation of YAP1 and FUS-DDIT3 in myxoid liposarcoma
por: Berthold, Ruth, et al.
Publicado: (2022)

Truncated SSX Protein Suppresses Synovial Sarcoma Cell Proliferation by Inhibiting the Localization of SS18-SSX Fusion Protein
por: Yoneda, Yasushi, et al.
Publicado: (2013)

The clinical implication of SS18-SSX fusion gene in synovial sarcoma
por: Ren, T, et al.
Publicado: (2013)

Overcoming Heterogeneity of Antigen Expression for Effective CAR T Cell Targeting of Cancers
por: Kailayangiri, Sareetha, et al.
Publicado: (2020)

Proteomic signatures corresponding to the SS18/SSX fusion gene in synovial sarcoma
por: Ishii, Midori, et al.
Publicado: (2018)

Expanding the Use of an SS18-SSX Antibody for Molecular Assays in Synovial Sarcoma
por: Raquib, Ainiah Rushdiana, et al.
Publicado: (2022)

Usefulness of SS18-SSX antibody as a diagnostic marker for pulmonary metastatic synovial sarcoma
por: Miura, Kentaro, et al.
Publicado: (2021)

Surface expression of the immunotherapeutic target G(D2) in osteosarcoma depends on cell confluency
por: Wiebel, Malena, et al.
Publicado: (2021)

Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases
por: Przybyl, Joanna, et al.
Publicado: (2012)

Prognostic value of SS18–SSX fusion type in synovial sarcoma; systematic review and meta-analysis
por: Kubo, Tadahiko, et al.
Publicado: (2015)

Cooperation between SS18-SSX1 and miR-214 in Synovial Sarcoma Development and Progression
por: Tanaka, Miwa, et al.
Publicado: (2020)

Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas
por: Cheng, Yanli, et al.
Publicado: (2022)

SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier
por: Tamaki, Sakura, et al.
Publicado: (2015)

Detection of SS18-SSX1/2 fusion transcripts in circulating tumor cells of patients with synovial sarcoma
por: Przybyl, Joanna, et al.
Publicado: (2019)

A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18–SSX Induces Canonical BAF Destruction
por: Li, Jinxiu, et al.
Publicado: (2021)

β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition
por: Barrott, Jared J., et al.
Publicado: (2015)

T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G
por: Spurny, Christian, et al.
Publicado: (2017)

Expression of PSMA in tumor neovasculature of high grade sarcomas including synovial sarcoma, rhabdomyosarcoma, undifferentiated sarcoma and MPNST
por: Heitkötter, Birthe, et al.
Publicado: (2016)

SYT-SSX fusion genes and prognosis in synovial sarcoma
por: Mezzelani, A, et al.
Publicado: (2001)

MDM2 amplification and fusion gene ss18-ssx in a poorly differentiated synovial sarcoma: A rare but puzzling conjunction
por: Di Mauro, Ilaria, et al.
Publicado: (2020)

Diagnostic tools in the differential diagnosis of giant cell-rich lesions of bone at biopsy
por: Rehkämper, Jan, et al.
Publicado: (2018)

Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma
por: Peng, Changliang, et al.
Publicado: (2016)

Primary monophasic synovial sarcoma of the cervical esophagus confirmed by detection of the SS18-SSX2 fusion transcripts: case report and literature review
por: Sasaki, Ken, et al.
Publicado: (2020)

The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma
por: Cironi, Luisa, et al.
Publicado: (2016)

SS18-SSX-regulated miR-17 promotes tumor growth of synovial sarcoma by inhibiting p21WAF1/CIP1
por: Minami, Yusuke, et al.
Publicado: (2014)

Regulators of Actin Dynamics in Gastrointestinal Tract Tumors
por: Steinestel, Konrad, et al.
Publicado: (2015)

SSX expression and function in prostate cancer
por: Bloom, Jordan E, et al.
Publicado: (2013)

Focal adhesion kinase confers pro‐migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma
por: Steinestel, Konrad, et al.
Publicado: (2019)

Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma
por: Fuest, Sebastian, et al.
Publicado: (2022)

HLA-G and HLA-E Immune Checkpoints Are Widely Expressed in Ewing Sarcoma but Have Limited Functional Impact on the Effector Functions of Antigen-Specific CAR T Cells
por: Altvater, Bianca, et al.
Publicado: (2021)

Higher Expression Levels of SSX1 and SSX2 in Patients with Colon Cancer: Regulated In Vitro by the Inhibition of Methylation and Histone Deacetylation
por: Alrubie, Turki M., et al.
Publicado: (2023)

CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process
por: Altvater, Bianca, et al.
Publicado: (2023)

Neovascular PSMA expression is a common feature in malignant neoplasms of the thyroid
por: Heitkötter, Birthe, et al.
Publicado: (2018)

SSX2IP helps the centrosome grow up
por: Leslie, Mitch
Publicado: (2013)

SSX addiction in melanoma propagates tumor growth and metastasis
por: Traynor, Sofie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c6lhvs8u0k8c8lgvugc7hjtgvi